Sign In
Buy CRVS
$11.60
-0.0900 (-0.770%)
At Close: Jun 03, 2026
Nanobiotix Announces Revenue for Second Quarter 2020 and First Half Year 2020
12:00am, Friday, 17'th Jul 2020
Regulatory News: NANOBIOTIX (Paris:NANO) (Euronext : NANO – ISIN : FR0011341205 – the ‘‘Company’’), a late clinical-stage nanomedicine company pioneer
Corvus Pharmaceuticals (CRVS) Catches Eye: Stock Jumps 8.4%
12:43pm, Thursday, 09'th Jul 2020
Corvus Pharmaceuticals (CRVS) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
Biotech Stock Roundup: REGN Initiates Coronavirus Study, NVAX Surges & More
02:22pm, Wednesday, 08'th Jul 2020
The biotech sector remains in focus with updates on coronavirus treatments and other pipeline updates.
Corvus Starts Immunotherapy Study on Coronavirus, Stock Rises
01:58pm, Wednesday, 08'th Jul 2020
Shares of Corvus (CRVS) rise as it commences a phase I study to investigate a novel immunotherapy approach for patients with COVID-19.
Wall Street Analysts Are Bullish on Top Healthcare Picks - Markets
10:16am, Wednesday, 08'th Jul 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Avadel Pharmaceuticals
The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy
12:00am, Wednesday, 08'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 7)
AbbVie Inc (NYSE: ABBV)...
Coronavirus update: U.S. COVID-19 cases climb above 2.9 million; ‘We’re still knee-deep in the first wave,’ Dr. Fauci warns
07:07pm, Tuesday, 07'th Jul 2020
The number of U.S. cases of the coronavirus illness COVID-19 climbed above 2.9 million on Tuesday, as Dr. Anthony Fauci warned Americans the country is...
Corvus Shoots Up 115% On Start Of Novel Immunotherapy Study In Covid-19 Patients
01:53pm, Tuesday, 07'th Jul 2020
Corvus Pharmaceuticals Inc. (CRVS) shares shot up 115% on Tuesday after the clinical-stage biopharma company said that it has initiated a Phase 1 study to investigate a novel immunotherapy approach fo
Corvus stock jumps on launch of early-stage trial for coronavirus treatment
01:32pm, Tuesday, 07'th Jul 2020
Shares of Corvus Pharmaceuticals Inc. soared 81.2% in trading on Tuesday after the company said it launched an open-label Phase 1 clinical trial testing an experimental monoclonal antibody as a treat
Corvus Shares Jump as Study of Novel Virus Therapy Begins
12:51pm, Tuesday, 07'th Jul 2020
Corvus Pharmaceuticals shares jumped after the clinical-stage biopharm said it had initiated a Phase I study of a novel immunotherapy approach for coronavirus patients. At last check Corvus shares w
Corvus Pharmaceuticals Initiates Clinical Trial of Novel Immunotherapy for Patients with COVID-19
11:00am, Tuesday, 07'th Jul 2020
Corvus Pharmaceuticals, Inc. (CRVS), a clinical-stage biopharmaceutical company, today announced that it has initiated a Phase 1 study to investigate a novel immunotherapy approach for patients with C
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.51%
12:00am, Tuesday, 07'th Jul 2020
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.51%
Should You Buy Corvus Pharmaceuticals, Inc. (CRVS)?
10:12pm, Friday, 03'rd Jul 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
iTeos Therapeutics Begins U.S. IPO Rollout
03:59pm, Thursday, 02'nd Jul 2020
iTeos Therapeutics has filed to raise $100 million in a U.S. IPO. The firm is developing drug candidates to treat solid tumors and other cancer indications. ITO
Analysts Are Bullish on These Healthcare Stocks: Avid Bioservices (CDMO), Vericel (VCEL) - Markets
10:16am, Wednesday, 01'st Jul 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Avid Bioservices
